• Almasy L. and Blangero J. (1998) Multipoint quantitative-trait linkage analysis in general pedigrees. Am. J. Hum. Genet. 62, 11981211.
  • Brinton T. J., Kailasam M. T., Wu R. A., Cervenka J. H., Chio S. S., Parmer R. J., DeMaria A. N. and O'Connor D. T. (1996) Arterial compliance by cuff sphygmomanometer. Application to hypertension and early changes in subjects at genetic risk. Hypertension 28, 599603.
  • Cockburn M., Hamilton A., Zadnick J., Cozen W. and Mack T. M. (2002) The occurrence of chronic disease and other conditions in a large population-based cohort of native Californian twins. Twin Res. 5, 460467.
  • Coral-Vazquez R., Cohn R. D., Moore S. A. et al. (1999) Disruption of the sarcoglycansarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell 98, 465474.
  • Davis J. T., Rao F., Naqshbandi D., Fung M. M., Zhang K., Schork A. J., Nievergelt C. M., Ziegler M. G. and O'Connor D. T. (2012) Autonomic and hemodynamic origins of pre-hypertension: central role of heredity. J. Am. Coll. Cardiol. 59, 22062216.
  • Escobales N. and Crespo M. J. (2008) Early pathophysiological alterations in experimental cardiomyopathy: the Syrian cardiomyopathic hamster. P. R. Health Sci. J. 27, 307314.
  • Hasking G. J., Esler M. D., Jennings G. L., Burton D., Johns J. A. and Korner P. I. (1986) Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 73, 615621.
  • Heydemann A., Demonbreun A., Hadhazy M., Earley J. U. and McNally E. M. (2007) Nuclear sequestration of delta-sarcoglycan disrupts the nuclear localization of lamin A/C and emerin in cardiomyocytes. Hum. Mol. Genet. 16, 355363.
  • Lee Y. W., Oh V. M., Garcia E., Taylor E. A., Wu H., Yap E. P., Kazeem G. R., Caulfield M. J. and Munroe P. B. (2004) Haplotypes of the beta2-adrenergic receptor gene are associated with essential hypertension in a Singaporean Chinese population. J. Hypertens. 22, 21112116.
  • Levey A. S., Stevens L. A., Schmid C. H. et al. (2009) A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604612.
  • Nigro V., Okazaki Y., Belsito A. et al. (1997) Identification of the Syrian hamster cardiomyopathy gene. Hum. Mol. Genet. 6, 601607.
  • Okazaki Y., Okuizumi H., Ohsumi T. et al. (1996) A genetic linkage map of the Syrian hamster and localization of cardiomyopathy locus on chromosome 9qa2.1-b1 using RLGS spot-mapping. Nat. Genet. 13, 8790.
  • Parati G. and Esler M. (2012) The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur. Heart J. 33, 10581066.
  • Sandelin A., Wasserman W. W. and Lenhard B. (2004) ConSite: web-based prediction of regulatory elements using cross-species comparison. Nucleic Acids Res. 32, W249W252.
  • Schadt E. E., Molony C., Chudin E. et al. (2008) Mapping the genetic architecture of gene expression in human liver. PLoS Biol. 6, e107.
  • Schroeder C. and Jordan J. (2012) Norepinephrine transporter function and human cardiovascular disease. Am. J. Physiol. Heart Circ. Physiol. 303, H1273H1282.
  • Sole M. J., Lo C. M., Laird C. W., Sonnenblick E. H. and Wurtman R. J. (1975) Norepinephrine turnover in the heart and spleen of the cardiomyopathic Syrian hamster. Circ. Res. 37, 855862.
  • Steinberg D., Nestel P. J., Buskirk E. R. and Thompson R. H. (1964) Calorigenic effect of norepinephrine correlated with plasma free fatty acid turnover and oxidation. J. Clin. Invest. 43, 167176.
  • Taupenot L. (2007) Analysis of regulated secretion using PC12 cells. Curr. Protoc. Cell Biol. 15, 12.112.12.
  • Taupenot L., Harper K. L., Mahapatra N. R., Parmer R. J., Mahata S. K. and O'Connor D. T. (2002) Identification of a novel sorting determinant for the regulated pathway in the secretory protein chromogranin A. J. Cell Sci. 115, 48274841.
  • Vainzof M., Ayub-Guerrieri D., Onofre P. C., Martins P. C., Lopes V. F., Zilberztajn D., Maia L. S., Sell K. and Yamamoto L. U. (2008) Animal models for genetic neuromuscular diseases. J. Mol. Neurosci. 34, 241248.
  • Wessel J., Moratorio G., Rao F. et al. (2007) C-reactive protein, an ‘intermediate phenotype’ for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/beta-adrenergic pathway loci. J. Hypertens. 25, 329343.
  • Yamada S., Ohkura T., Yamadera T., Ito O., Kimura R., Nozawa Y., Hayashi S. and Miyake H. (1997) Abnormality in plasma catecholamines and myocardial adrenoceptors in cardiomyopathic BIO 53.58 Syrian hamsters and improvement by metoprolol treatment. J. Pharmacol. Exp. Ther. 283, 13891395.
  • Zhang L., Rao F., Wessel J. et al. (2004) Functional allelic heterogeneity and pleiotropy of a repeat polymorphism in tyrosine hydroxylase: prediction of catecholamines and response to stress in twins. Physiol. Genomics 19, 277291.
  • Ziegler M. G., Kennedy B. and Elayan H. (1988) A sensitive radioenzymatic assay for epinephrine forming enzymes. Life Sci. 43, 21172122.